US Stock MarketDetailed Quotes

INBX Inhibrx Biosciences

Watchlist
  • 16.050
  • +0.340+2.16%
Close Nov 6 16:00 ET
  • 16.050
  • 0.0000.00%
Post 16:00 ET
232.34MMarket Cap0.14P/E (TTM)

Inhibrx Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
Total revenue
233.33%100K
0
25.60%1.63M
30K
0
1.3M
Operating revenue
233.33%100K
--0
25.60%1.63M
--30K
--0
--1.3M
Cost of revenue
Gross profit
Operating expense
289.18%161M
24.46%49.21M
32.37%154.38M
41.37M
39.54M
116.62M
Selling and administrative expenses
1,185.50%93.37M
64.64%8.78M
61.28%24.25M
--7.26M
--5.33M
--15.04M
-General and administrative expense
1,185.50%93.37M
64.64%8.78M
61.28%24.25M
--7.26M
--5.33M
--15.04M
Research and development costs
98.30%67.63M
18.20%40.43M
28.08%130.13M
--34.11M
--34.21M
--101.6M
Other operating expenses
----
----
----
----
----
---14K
Operating profit
-289.22%-160.9M
-24.46%-49.21M
-32.45%-152.75M
-41.34M
-39.54M
-115.32M
Net non-operating interest income expense
52.29%-2.62M
-5.49M
Non-operating interest income
13.55%2.74M
----
----
--2.41M
----
----
Non-operating interest expense
-32.18%5.36M
----
----
--7.91M
----
----
Other net income (expense)
931,681.11%2.02B
15.71%-59K
-58,100.00%-580K
-217K
-70K
1K
Special income (charges)
--2.02B
----
----
--0
----
----
-Less：Restructuring and merger&acquisition
---2.02B
----
----
--0
----
----
Other non- operating income (expenses)
115.21%33K
15.71%-59K
-58,100.00%-580K
---217K
---70K
--1K
Income before tax
4,049.27%1.86B
-24.39%-49.27M
-32.96%-153.33M
-47.05M
-39.61M
-115.32M
Income tax
-60.00%2K
0.00%3K
5K
3K
Earnings from equity interest net of tax
----
----
---1.63M
----
----
--0
Net income
4,048.85%1.86B
-24.39%-49.27M
-34.37%-154.96M
-47.05M
-39.61M
-115.33M
Net income continuous Operations
4,048.85%1.86B
-24.39%-49.27M
-34.37%-154.96M
---47.05M
---39.61M
---115.33M
Minority interest income
Net income attributable to the parent company
4,048.85%1.86B
-24.39%-49.27M
-34.37%-154.96M
-47.05M
-39.61M
-115.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
4,048.85%1.86B
-24.39%-49.27M
-34.37%-154.96M
-47.05M
-39.61M
-115.33M
Basic earnings per share
3,946.92%127.1
-24.39%-3.4599
-34.37%-10.8814
-3.3039
-2.7814
-8.098
Diluted earnings per share
3,897.89%125.48
-24.39%-3.4599
-34.37%-10.8814
-3.3039
-2.7814
-8.098
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
(Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022
Total revenue 233.33%100K 0 25.60%1.63M 30K 0 1.3M
Operating revenue 233.33%100K --0 25.60%1.63M --30K --0 --1.3M
Cost of revenue
Gross profit
Operating expense 289.18%161M 24.46%49.21M 32.37%154.38M 41.37M 39.54M 116.62M
Selling and administrative expenses 1,185.50%93.37M 64.64%8.78M 61.28%24.25M --7.26M --5.33M --15.04M
-General and administrative expense 1,185.50%93.37M 64.64%8.78M 61.28%24.25M --7.26M --5.33M --15.04M
Research and development costs 98.30%67.63M 18.20%40.43M 28.08%130.13M --34.11M --34.21M --101.6M
Other operating expenses ---- ---- ---- ---- ---- ---14K
Operating profit -289.22%-160.9M -24.46%-49.21M -32.45%-152.75M -41.34M -39.54M -115.32M
Net non-operating interest income expense 52.29%-2.62M -5.49M
Non-operating interest income 13.55%2.74M ---- ---- --2.41M ---- ----
Non-operating interest expense -32.18%5.36M ---- ---- --7.91M ---- ----
Other net income (expense) 931,681.11%2.02B 15.71%-59K -58,100.00%-580K -217K -70K 1K
Special income (charges) --2.02B ---- ---- --0 ---- ----
-Less：Restructuring and merger&acquisition ---2.02B ---- ---- --0 ---- ----
Other non- operating income (expenses) 115.21%33K 15.71%-59K -58,100.00%-580K ---217K ---70K --1K
Income before tax 4,049.27%1.86B -24.39%-49.27M -32.96%-153.33M -47.05M -39.61M -115.32M
Income tax -60.00%2K 0.00%3K 5K 3K
Earnings from equity interest net of tax ---- ---- ---1.63M ---- ---- --0
Net income 4,048.85%1.86B -24.39%-49.27M -34.37%-154.96M -47.05M -39.61M -115.33M
Net income continuous Operations 4,048.85%1.86B -24.39%-49.27M -34.37%-154.96M ---47.05M ---39.61M ---115.33M
Minority interest income
Net income attributable to the parent company 4,048.85%1.86B -24.39%-49.27M -34.37%-154.96M -47.05M -39.61M -115.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 4,048.85%1.86B -24.39%-49.27M -34.37%-154.96M -47.05M -39.61M -115.33M
Basic earnings per share 3,946.92%127.1 -24.39%-3.4599 -34.37%-10.8814 -3.3039 -2.7814 -8.098
Diluted earnings per share 3,897.89%125.48 -24.39%-3.4599 -34.37%-10.8814 -3.3039 -2.7814 -8.098
Dividend per share
Currency Unit USD USD USD USD USD USD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Recent IPOs
Recent IPOs
Intraday+1.93%